Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>APOE ε4</i> and Alzheimer's disease biomarkers in an American Indian community.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Long-term follow-up and response to elosulfase alfa in mucopolysaccharidosis type IVA: a single-center cohort from the Czech Republic.

Orphanet journal of rare diseases·2026
Same author

Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis.

Molecular genetics and metabolism·2026
Same author

<i>PTPN1</i>-related autoinflammation is a common cause of Aicardi-Goutières Syndrome with reduced penetrance.

medRxiv : the preprint server for health sciences·2026
Same author

Long-term Natural History and Elosulfase Alfa Treatment for Mucopolysaccharidosis Type IVA: A Single-Center Study in the Czech Republic.

Research square·2026
Same author

Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension.

Nature communications·2026

Related Experiment Video

Updated: May 4, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K

Quantitative neuroimaging in mucolipidosis type IV.

Raphael Schiffmann1, Joan Mayfield2, Caren Swift1

  • 1Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX, USA.

Molecular Genetics and Metabolism
|December 17, 2013
PubMed
Summary

Mucolipidosis type IV (MLIV), caused by MCOLN1 gene mutations, may involve a slow neurodegenerative process. Diffusion imaging shows brain changes, suggesting it as a biomarker for MLIV patients.

Keywords:
Lysosomal disorderMucolipidosisNatural historyVolumetry

More Related Videos

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ
08:44

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ

Published on: August 3, 2018

9.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Related Experiment Videos

Last Updated: May 4, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

3.8K
Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ
08:44

Quantitative Cell Biology of Neurodegeneration in Drosophila Through Unbiased Analysis of Fluorescently Tagged Proteins Using ImageJ

Published on: August 3, 2018

9.9K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K

Area of Science:

  • Neuroscience
  • Genetics
  • Medical Imaging

Background:

  • Mucolipidosis type IV (MLIV) is an autosomal recessive disorder linked to MCOLN1 gene mutations.
  • MLIV patients exhibit neurodevelopmental abnormalities and progressive retinal dystrophy.
  • The MCOLN1 gene encodes the mucolipin-1 (TRPML1) channel protein, crucial for endosomal/lysosomal function.

Purpose of the Study:

  • To investigate a potential slow cerebral neurodegenerative process in MLIV patients.
  • To assess neurodevelopmental status and brain structural changes over time.
  • To evaluate diffusion-weighted imaging as a biomarker for MLIV.

Main Methods:

  • Prospective natural history study involving 5 MLIV patients.
  • Annual neurodevelopmental assessments and MRI scans (regional volumes, white matter integrity).
  • Analysis of diffusion metrics: Mean Diffusivity (MD) and Fractional Anisotropy (FA).

Main Results:

  • MLIV patients remained neurologically stable over 3 years.
  • Trends observed: increased gray matter and ventricular volumes, decreased white matter and cerebellar volumes.
  • Elevated MD and reduced FA in all brain regions; correlations found between motor scores and FA/MD in the corticospinal tract.

Conclusions:

  • Mucolipin-1 deficiency impacts the entire brain, suggesting a selective regional neurodegenerative process in MLIV.
  • Diffusion-weighted imaging (DWI) shows promise as a biomarker for monitoring MLIV progression.
  • Findings may inform the design of future clinical trials for MLIV.